Exicure, Inc. announced that in connection with the closing of the Private Placement and pursuant to CBI USA's rights under the Securities Purchase Agreement, the Board appointed three CBI USA nominees to Exicure, Inc.'s Board, as follows: Paul Kang, Chang-il Ahn, and Hyuk-ku Lee. Following the appointment of Mr. Kang, Mr. Ahn, and Mr. Lee, Elizabeth Garofalo, M.D. tendered her resignation from the Board and as Chair of the Board, as well as from the Audit Committee, Compensation Committee and Nominating and Governance Committee of the Board, effective February 24, 2023.